Core Viewpoint - The company has provided a guarantee of 600 million RMB for its subsidiaries to secure bank credit facilities, which is expected to support their operational needs and promote sustainable development [1][4]. Summary by Sections Guarantee Overview - The total guarantee amount provided by the company for its subsidiaries is 60,000 million RMB [1]. - The guarantee is a joint liability guarantee without any counter-guarantee [1]. - There are no overdue guarantees reported [1]. Subsidiary Information - The subsidiaries involved in the guarantee include: - Xinjiang Kangzhiyuan Pharmaceutical Co., Ltd. with a guarantee of 6,000 million RMB [1]. - Yili Kangzhiyuan Pharmaceutical Chain Co., Ltd. with a guarantee of 6,000 million RMB [1]. - Luoyang Dacarelin Pharmaceutical Co., Ltd. with a guarantee of 5,000 million RMB [1]. - Yingkou Fujuhe Pharmaceutical Chain Co., Ltd. with a guarantee of 3,000 million RMB [1]. - Xuchang Dacarelin Baoyuantang Pharmacy Chain Co., Ltd. with a guarantee of 2,000 million RMB [1]. - Maoming Dacarelin Chain Pharmacy Co., Ltd. with a guarantee of 27,000 million RMB [1]. - Xinyang Dacarelin Baixingfu Pharmaceutical Chain Co., Ltd. with a guarantee of 6,000 million RMB [1]. Financial Health of Subsidiaries - The subsidiaries have shown stable financial conditions, with total assets and liabilities as follows: - Xinjiang Kangzhiyuan: Total assets of 223.76 million RMB, liabilities of 200.03 million RMB, and net profit of 4.60 million RMB [2]. - Yili Kangzhiyuan: Total assets of 223.25 million RMB, liabilities of 175.11 million RMB, and net profit of 4.91 million RMB [2]. - Luoyang Dacarelin: Total assets of 408.73 million RMB, liabilities of 257.37 million RMB, and net profit of 14.47 million RMB [2]. - Yingkou Fujuhe: Total assets of 78.20 million RMB, liabilities of 49.33 million RMB, and net profit of 1.13 million RMB [2]. - Xuchang Dacarelin: Total assets of 90.55 million RMB, liabilities of 67.47 million RMB, and net profit of 1.37 million RMB [2]. - Maoming Dacarelin: Total assets of 1,992.40 million RMB, liabilities of 1,167.19 million RMB, and net profit of 131.63 million RMB [2]. - Xinyang Dacarelin: Total assets of 87.87 million RMB, liabilities of 45.28 million RMB, and net profit of 1.02 million RMB [2]. Necessity and Reasonableness of Guarantee - The guarantee is deemed necessary to meet the operational needs of the subsidiaries and aligns with the company's overall interests and development strategy [4]. - The subsidiaries are reported to have stable financial conditions and good creditworthiness, indicating their ability to repay the debts [4]. Cumulative External Guarantee - As of the announcement date, the total amount of guarantees signed after the 2024 annual general meeting authorization is 600 million RMB, accounting for 6.95% of the company's latest audited net assets [5]. - There are no overdue external guarantees or guarantees involving litigation reported [5].
大参林: 大参林医药集团股份有限公司关于为子公司提供担保的进展公告